UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015179 |
|---|---|
| Receipt number | R000017622 |
| Scientific Title | The efficacy of intravenous immunoglobulin(IVIG) for the maintenance phase of treatment for children with acute lymphoblastic leukemia(ALL) |
| Date of disclosure of the study information | 2014/09/16 |
| Last modified on | 2015/05/20 21:52:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance
phase of treatment for children with acute lymphoblastic leukemia(ALL)
Acronym
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance
phase of treatment for children with acute lymphoblastic leukemia(ALL)
Scientific Title
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance
phase of treatment for children with acute lymphoblastic leukemia(ALL)
Scientific Title:Acronym
The efficacy of intravenous immunoglobulin(IVIG) for the maintenance
phase of treatment for children with acute lymphoblastic leukemia(ALL)
Region
| Japan |
Condition
Condition
Acute lymphoblastic leukemia
Classification by specialty
| Child |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to evaluate the efficacy and safety of ntravenous immunoglobulin(IVIG) for the maintenance
phase of treatment for children with acute lymphoblastic leukemia(ALL).
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The rate of infection.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
administration of immunoglobulin
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 0 | years-old | <= |
Age-upper limit
| 18 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients with acute lymphoblastic leukemia
Key exclusion criteria
none
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hideki Muramatsu |
Organization
Nagoya University Graduate School of Medicine
Division name
Department of pediatrics,
Zip code
Address
65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8650, Japan
TEL
052-744-2294
hideki-muramatsu@med.nagoya-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Atsushi Narita |
Organization
Nagoya University Graduate School of Medicine
Division name
Department of pediatrics,
Zip code
Address
65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8650, Japan
TEL
052-744-2294
Homepage URL
stanza-la-speranza@nifty.com
Sponsor or person
Institute
Nagoya University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
a research grant
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 09 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2014 | Year | 09 | Month | 16 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 09 | Month | 16 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2014 | Year | 09 | Month | 16 | Day |
Last modified on
| 2015 | Year | 05 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017622
